| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/29/2006 | WO2006068212A1 Lipase inhibitor and preventive/remedy for skin diseases |
| 06/29/2006 | WO2006068187A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein |
| 06/29/2006 | WO2006068163A1 Bicyclic pyrrole derivatives |
| 06/29/2006 | WO2006068133A1 Method of suppressing expression of nfat2 |
| 06/29/2006 | WO2006068041A1 Composition having effect of promoting the decomposition of body fat and food or food additive containing the same |
| 06/29/2006 | WO2006067985A1 Novel polyphenol glycoside derived from acerola |
| 06/29/2006 | WO2006067856A1 Functional food or pharmaceutical and process for producing the same |
| 06/29/2006 | WO2006067175A1 Medicaments for the treatment or prevention of fibrotic diseases |
| 06/29/2006 | WO2006066987A1 Anti-radical agents |
| 06/29/2006 | WO2006066949A1 Compositions comprising an epothilone and production methods |
| 06/29/2006 | WO2005107730A3 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/29/2006 | US20060142580 N-phenyl-2-pyrimidine-amine derivatives |
| 06/29/2006 | US20060142388 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 06/29/2006 | US20060142360 Having a central trivalent nitrogen atom to which is attached either direct or indirectly three ring systems, at least one of which is substituted by a sulfamate group and one by a halogen; steroid sulfatase and aromatase inhibitors |
| 06/29/2006 | US20060142342 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 06/29/2006 | US20060142341 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 06/29/2006 | US20060142336 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/29/2006 | US20060142330 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's and attention deficit disorder, schizophrenia, obsessive compulsive disorders, |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142306 Bronchodilator agents; respiratory system disorders; skin disorders ; asthma; hypotensive agents |
| 06/29/2006 | US20060142292 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 06/29/2006 | US20060142289 Method of treating migraine headaches |
| 06/29/2006 | US20060142281 Indolinone derivatives |
| 06/29/2006 | US20060142280 Such as 4-(4,4-Dimethyl-2-thioxo-1,4-dihydro-2H-benzo[d][1 ,3]oxazin-6-yl)-thiophene-2-carbonitrile; estrogen receptor agonists, progesterone receptor antagonists; hormone replacement therapy |
| 06/29/2006 | US20060142268 1,4,5,6-tetrahydroimidazo[4,5-d]benzazepine derivative or salt thereof |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060142254 Antipyretic preparation containing xylitol |
| 06/29/2006 | US20060142236 Antisense oligonucleotide modulation of raf gene expression |
| 06/29/2006 | US20060142222 Novel gene relating to fibrotic conditions |
| 06/29/2006 | US20060142218 Method of controlling telomere length |
| 06/29/2006 | US20060142212 Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 06/29/2006 | US20060142209 Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 06/29/2006 | US20060142203 Antiproliferative agents; angiogenese inhibitors; antiinflammatory agents; anticancer agents |
| 06/29/2006 | US20060142183 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/29/2006 | US20060141599 Crystals of Glucokinase and methods of growing them |
| 06/29/2006 | US20060141579 Cytokine zcytor17 ligand polynucleotides |
| 06/29/2006 | US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 06/29/2006 | US20060141476 Growth arrest homeobox gene |
| 06/29/2006 | US20060141080 Extracting crushed plant material Cuminum cyminum with water or 50% aqueous alcoholic solvent; extracting a portion of the aqueous extract with n-butanol, separating -butanol layer and an aqueous layer, evaporating, and freeze drying the aqueous layer |
| 06/29/2006 | US20060141079 Supplement foods and pharmaceuticals |
| 06/29/2006 | US20060141042 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 06/29/2006 | US20060140962 Combination treatment of pancreatic cancer |
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140928 Use of heparinases to decrease inflammatory response |
| 06/29/2006 | US20060140925 Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use |
| 06/29/2006 | US20060140907 Central airway administration for systemic delivery of therapeutics |
| 06/29/2006 | DE102004062468A1 Composition (for vaginal application), useful for influencing the genitalia of the mammalian offsprings, comprises thickeners |
| 06/29/2006 | DE10038110B4 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 06/29/2006 | CA2595517A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 06/29/2006 | CA2592470A1 Method for inducing differentiation to skeletal muscle cells |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2591997A1 Compositions comprising an epothilone and production methods |
| 06/29/2006 | CA2591089A1 Medicaments for the treatment or prevention of fibrotic diseases |
| 06/29/2006 | CA2591083A1 Medicaments for the treatment or prevention of fibrotic diseases |
| 06/29/2006 | CA2590912A1 Bicyclic pyrrole derivatives |
| 06/28/2006 | EP1674456A2 Substituted alpha-halo-beta-keto-pyridinylpropanoates |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674112A1 Compositions comprising an inhibitor of an acrab-like efflux pump for reducing microbial resistance to drugs |
| 06/28/2006 | EP1674108A2 Osteoporosis treatment |
| 06/28/2006 | EP1674106A1 Dietetic composition |
| 06/28/2006 | EP1674102A1 Use of flibanserin in the treatment of sexual disorders |
| 06/28/2006 | EP1674099A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 06/28/2006 | EP1674098A1 Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
| 06/28/2006 | EP1674092A1 Amino acid compositions |
| 06/28/2006 | EP1673076A1 Breast cancer treatment regimen |
| 06/28/2006 | EP1569900B1 Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/28/2006 | EP1569899B1 Substituted 3-alkyl- and 3-arylalkyl-1h-indol-1-yl-acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/28/2006 | EP1544201B1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 06/28/2006 | EP1492539B1 Statin therapy for enhancing cognitive maintenance |
| 06/28/2006 | EP1401812B1 4-piperazinylindole derivatives with 5-ht6 receptor affinity |
| 06/28/2006 | EP1379258B1 Low salt forms of polyallylamine |
| 06/28/2006 | EP1355644B1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 06/28/2006 | EP1280500B1 Synergistic antiplaque/antigingivitis oral composition |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1267901B9 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 06/28/2006 | EP1259243B1 Bupropion metabolites and methods of their synthesis and use |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP1229894B8 Cosmetic compositions containing chick pea extract and retinoids |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1121372B1 Adenine derivatives |
| 06/28/2006 | EP1060251B1 Phosphodiesterase 10 |
| 06/28/2006 | EP1041990B1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 06/28/2006 | EP0951281B1 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 06/28/2006 | EP0876143B1 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals |
| 06/28/2006 | EP0832227B9 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 06/28/2006 | EP0693129B1 Method of inhibiting the transcription of genes |
| 06/28/2006 | CN1795265A Control of stem cell differentiation induction and differentiation potency |
| 06/28/2006 | CN1795196A Agent for repairing corneal sensitivity containing amide compound |
| 06/28/2006 | CN1794993A Medicinal composition containing benidipine hydrochloride |
| 06/28/2006 | CN1793175A Cell shifting related protein and its coding gene and application |
| 06/28/2006 | CN1792280A Beverage of yellow mallow |
| 06/28/2006 | CN1792279A Beverage for relieving summer heat and its prepn. method |